1 Market Overview

1.1 Product Overview and Scope of Generic Medicine

1.2 Classification of Generic Medicine by Type

1.2.1 Overview: Global Generic Medicine Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Generic Medicine Revenue Market Share by Type in 2020

1.2.3 Simple Generic Drugs

1.2.4 Super Generic Drugs

1.2.5 Biosimilars

1.2.6 By Application:

1.2.7 CNS

1.2.8 Cardiovascular

1.2.9 Respiratory

1.2.10 Rheumatology

1.2.11 Diabetes

1.2.12 Oncology

1.3 Global Generic Medicine Market by Application

1.3.1 Overview: Global Generic Medicine Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Respiratory

1.3.5 Rheumatology

1.3.6 Diabetes

1.3.7 Oncology

1.3.8 Others

1.4 Global Generic Medicine Market Size & Forecast

1.5 Global Generic Medicine Market Size and Forecast by Region

1.5.1 Global Generic Medicine Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Generic Medicine Market Size by Region, (2016-2021)

1.5.3 North America Generic Medicine Market Size and Prospect (2016-2026)

1.5.4 Europe Generic Medicine Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Generic Medicine Market Size and Prospect (2016-2026)

1.5.6 South America Generic Medicine Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Generic Medicine Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Generic Medicine Market Drivers

1.6.2 Generic Medicine Market Restraints

1.6.3 Generic Medicine Trends Analysis

2 Company Profiles

2.1 Teva

2.1.1 Teva Details

2.1.2 Teva Major Business

2.1.3 Teva Generic Medicine Product and Solutions

2.1.4 Teva Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Teva Recent Developments and Future Plans

2.2 Novartis - Sandoz

2.2.1 Novartis - Sandoz Details

2.2.2 Novartis - Sandoz Major Business

2.2.3 Novartis - Sandoz Generic Medicine Product and Solutions

2.2.4 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis - Sandoz Recent Developments and Future Plans

2.3 Mylan

2.3.1 Mylan Details

2.3.2 Mylan Major Business

2.3.3 Mylan Generic Medicine Product and Solutions

2.3.4 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Mylan Recent Developments and Future Plans

2.4 Sun Pharmaceutical

2.4.1 Sun Pharmaceutical Details

2.4.2 Sun Pharmaceutical Major Business

2.4.3 Sun Pharmaceutical Generic Medicine Product and Solutions

2.4.4 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Sun Pharmaceutical Recent Developments and Future Plans

2.5 Aspen

2.5.1 Aspen Details

2.5.2 Aspen Major Business

2.5.3 Aspen Generic Medicine Product and Solutions

2.5.4 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Aspen Recent Developments and Future Plans

2.6 Fresenius Kabi

2.6.1 Fresenius Kabi Details

2.6.2 Fresenius Kabi Major Business

2.6.3 Fresenius Kabi Generic Medicine Product and Solutions

2.6.4 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Fresenius Kabi Recent Developments and Future Plans

2.7 Pfizer (Hospira)

2.7.1 Pfizer (Hospira) Details

2.7.2 Pfizer (Hospira) Major Business

2.7.3 Pfizer (Hospira) Generic Medicine Product and Solutions

2.7.4 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Pfizer (Hospira) Recent Developments and Future Plans

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Generic Medicine Product and Solutions

2.8.4 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Sanofi Recent Developments and Future Plans

2.9 Aurobindo

2.9.1 Aurobindo Details

2.9.2 Aurobindo Major Business

2.9.3 Aurobindo Generic Medicine Product and Solutions

2.9.4 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Aurobindo Recent Developments and Future Plans

2.10 Lupin

2.10.1 Lupin Details

2.10.2 Lupin Major Business

2.10.3 Lupin Generic Medicine Product and Solutions

2.10.4 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Lupin Recent Developments and Future Plans

2.11 Dr. Reddy's

2.11.1 Dr. Reddy's Details

2.11.2 Dr. Reddy's Major Business

2.11.3 Dr. Reddy's Generic Medicine Product and Solutions

2.11.4 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Dr. Reddy's Recent Developments and Future Plans

2.12 Apotex

2.12.1 Apotex Details

2.12.2 Apotex Major Business

2.12.3 Apotex Generic Medicine Product and Solutions

2.12.4 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Apotex Recent Developments and Future Plans

2.13 Cipla

2.13.1 Cipla Details

2.13.2 Cipla Major Business

2.13.3 Cipla Generic Medicine Product and Solutions

2.13.4 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Cipla Recent Developments and Future Plans

2.14 ENDO (Par Pharmaceutical)

2.14.1 ENDO (Par Pharmaceutical) Details

2.14.2 ENDO (Par Pharmaceutical) Major Business

2.14.3 ENDO (Par Pharmaceutical) Generic Medicine Product and Solutions

2.14.4 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 ENDO (Par Pharmaceutical) Recent Developments and Future Plans

2.15 Stada Arzneimittel

2.15.1 Stada Arzneimittel Details

2.15.2 Stada Arzneimittel Major Business

2.15.3 Stada Arzneimittel Generic Medicine Product and Solutions

2.15.4 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Stada Arzneimittel Recent Developments and Future Plans

2.16 Krka Group

2.16.1 Krka Group Details

2.16.2 Krka Group Major Business

2.16.3 Krka Group Generic Medicine Product and Solutions

2.16.4 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Krka Group Recent Developments and Future Plans

2.17 Nichi-Iko Pharmaceutical

2.17.1 Nichi-Iko Pharmaceutical Details

2.17.2 Nichi-Iko Pharmaceutical Major Business

2.17.3 Nichi-Iko Pharmaceutical Generic Medicine Product and Solutions

2.17.4 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Nichi-Iko Pharmaceutical Recent Developments and Future Plans

2.18 Valeant

2.18.1 Valeant Details

2.18.2 Valeant Major Business

2.18.3 Valeant Generic Medicine Product and Solutions

2.18.4 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Valeant Recent Developments and Future Plans

2.19 Zydus Cadila

2.19.1 Zydus Cadila Details

2.19.2 Zydus Cadila Major Business

2.19.3 Zydus Cadila Generic Medicine Product and Solutions

2.19.4 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Zydus Cadila Recent Developments and Future Plans

2.20 Hikma

2.20.1 Hikma Details

2.20.2 Hikma Major Business

2.20.3 Hikma Generic Medicine Product and Solutions

2.20.4 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Hikma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Generic Medicine Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Generic Medicine Players Market Share

3.2.2 Top 10 Generic Medicine Players Market Share

3.2.3 Market Competition Trend

3.3 Generic Medicine Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Generic Medicine Revenue and Market Share by Type (2016-2021)

4.2 Global Generic Medicine Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Generic Medicine Revenue Market Share by Application (2016-2021)

5.2 Generic Medicine Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Generic Medicine Revenue by Type (2016-2026)

6.2 North America Generic Medicine Revenue by Application (2016-2026)

6.3 North America Generic Medicine Market Size by Country

6.3.1 North America Generic Medicine Revenue by Country (2016-2026)

6.3.2 United States Generic Medicine Market Size and Forecast (2016-2026)

6.3.3 Canada Generic Medicine Market Size and Forecast (2016-2026)

6.3.4 Mexico Generic Medicine Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Generic Medicine Revenue by Type (2016-2026)

7.2 Europe Generic Medicine Revenue by Application (2016-2026)

7.3 Europe Generic Medicine Market Size by Country

7.3.1 Europe Generic Medicine Revenue by Country (2016-2026)

7.3.2 Germany Generic Medicine Market Size and Forecast (2016-2026)

7.3.3 France Generic Medicine Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Generic Medicine Market Size and Forecast (2016-2026)

7.3.5 Russia Generic Medicine Market Size and Forecast (2016-2026)

7.3.6 Italy Generic Medicine Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Generic Medicine Revenue by Type (2016-2026)

8.2 Asia-Pacific Generic Medicine Revenue by Application (2016-2026)

8.3 Asia-Pacific Generic Medicine Market Size by Region

8.3.1 Asia-Pacific Generic Medicine Revenue by Region (2016-2026)

8.3.2 China Generic Medicine Market Size and Forecast (2016-2026)

8.3.3 Japan Generic Medicine Market Size and Forecast (2016-2026)

8.3.4 South Korea Generic Medicine Market Size and Forecast (2016-2026)

8.3.5 India Generic Medicine Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Generic Medicine Market Size and Forecast (2016-2026)

8.3.7 Australia Generic Medicine Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Generic Medicine Revenue by Type (2016-2026)

9.2 South America Generic Medicine Revenue by Application (2016-2026)

9.3 South America Generic Medicine Market Size by Country

9.3.1 South America Generic Medicine Revenue by Country (2016-2026)

9.3.2 Brazil Generic Medicine Market Size and Forecast (2016-2026)

9.3.3 Argentina Generic Medicine Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Generic Medicine Revenue by Type (2016-2026)

10.2 Middle East & Africa Generic Medicine Revenue by Application (2016-2026)

10.3 Middle East & Africa Generic Medicine Market Size by Country

10.3.1 Middle East & Africa Generic Medicine Revenue by Country (2016-2026)

10.3.2 Turkey Generic Medicine Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Generic Medicine Market Size and Forecast (2016-2026)

10.3.4 UAE Generic Medicine Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Generic Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Generic Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Generic Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Generic Medicine Revenue (USD Million) by Region (2016-2021)

Table 5. Global Generic Medicine Revenue Market Share by Region (2021-2026)

Table 6. Teva Corporate Information, Head Office, and Major Competitors

Table 7. Teva Major Business

Table 8. Teva Generic Medicine Product and Solutions

Table 9. Teva Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis - Sandoz Corporate Information, Head Office, and Major Competitors

Table 11. Novartis - Sandoz Major Business

Table 12. Novartis - Sandoz Generic Medicine Product and Solutions

Table 13. Novartis - Sandoz Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Mylan Corporate Information, Head Office, and Major Competitors

Table 15. Mylan Major Business

Table 16. Mylan Generic Medicine Product and Solutions

Table 17. Mylan Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 19. Sun Pharmaceutical Major Business

Table 20. Sun Pharmaceutical Generic Medicine Product and Solutions

Table 21. Sun Pharmaceutical Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Aspen Corporate Information, Head Office, and Major Competitors

Table 23. Aspen Major Business

Table 24. Aspen Generic Medicine Product and Solutions

Table 25. Aspen Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Fresenius Kabi Corporate Information, Head Office, and Major Competitors

Table 27. Fresenius Kabi Major Business

Table 28. Fresenius Kabi Generic Medicine Product and Solutions

Table 29. Fresenius Kabi Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Pfizer (Hospira) Corporate Information, Head Office, and Major Competitors

Table 31. Pfizer (Hospira) Major Business

Table 32. Pfizer (Hospira) Generic Medicine Product and Solutions

Table 33. Pfizer (Hospira) Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Sanofi Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi Major Business

Table 36. Sanofi Generic Medicine Product and Solutions

Table 37. Sanofi Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Aurobindo Corporate Information, Head Office, and Major Competitors

Table 39. Aurobindo Major Business

Table 40. Aurobindo Generic Medicine Product and Solutions

Table 41. Aurobindo Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Lupin Corporate Information, Head Office, and Major Competitors

Table 43. Lupin Major Business

Table 44. Lupin Generic Medicine Product and Solutions

Table 45. Lupin Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Dr. Reddy's Corporate Information, Head Office, and Major Competitors

Table 47. Dr. Reddy's Major Business

Table 48. Dr. Reddy's Generic Medicine Product and Solutions

Table 49. Dr. Reddy's Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Apotex Corporate Information, Head Office, and Major Competitors

Table 51. Apotex Major Business

Table 52. Apotex Generic Medicine Product and Solutions

Table 53. Apotex Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Cipla Corporate Information, Head Office, and Major Competitors

Table 55. Cipla Major Business

Table 56. Cipla Generic Medicine Product and Solutions

Table 57. Cipla Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. ENDO (Par Pharmaceutical) Corporate Information, Head Office, and Major Competitors

Table 59. ENDO (Par Pharmaceutical) Major Business

Table 60. ENDO (Par Pharmaceutical) Generic Medicine Product and Solutions

Table 61. ENDO (Par Pharmaceutical) Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Stada Arzneimittel Corporate Information, Head Office, and Major Competitors

Table 63. Stada Arzneimittel Major Business

Table 64. Stada Arzneimittel Generic Medicine Product and Solutions

Table 65. Stada Arzneimittel Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Krka Group Corporate Information, Head Office, and Major Competitors

Table 67. Krka Group Major Business

Table 68. Krka Group Generic Medicine Product and Solutions

Table 69. Krka Group Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Nichi-Iko Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 71. Nichi-Iko Pharmaceutical Major Business

Table 72. Nichi-Iko Pharmaceutical Generic Medicine Product and Solutions

Table 73. Nichi-Iko Pharmaceutical Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Valeant Corporate Information, Head Office, and Major Competitors

Table 75. Valeant Major Business

Table 76. Valeant Generic Medicine Product and Solutions

Table 77. Valeant Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 79. Zydus Cadila Major Business

Table 80. Zydus Cadila Generic Medicine Product and Solutions

Table 81. Zydus Cadila Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Hikma Corporate Information, Head Office, and Major Competitors

Table 83. Hikma Major Business

Table 84. Hikma Generic Medicine Product and Solutions

Table 85. Hikma Generic Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Generic Medicine Revenue (USD Million) by Players (2019-2021)

Table 87. Global Generic Medicine Revenue Share by Players (2019-2021)

Table 88. Breakdown of Generic Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Generic Medicine Players Head Office, Products and Services Provided

Table 90. Generic Medicine Mergers & Acquisitions in the Past Five Years

Table 91. Generic Medicine New Entrants and Expansion Plans

Table 92. Global Generic Medicine Revenue (USD Million) by Type (2016-2021)

Table 93. Global Generic Medicine Revenue Share by Type (2016-2021)

Table 94. Global Generic Medicine Revenue Forecast by Type (2021-2026)

Table 95. Global Generic Medicine Revenue by Application (2016-2021)

Table 96. Global Generic Medicine Revenue Forecast by Application (2021-2026)

Table 97. North America Generic Medicine Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Generic Medicine Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Generic Medicine Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Generic Medicine Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Generic Medicine Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Generic Medicine Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Generic Medicine Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Generic Medicine Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Generic Medicine Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Generic Medicine Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Generic Medicine Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Generic Medicine Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Generic Medicine Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Generic Medicine Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Generic Medicine Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Generic Medicine Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Generic Medicine Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Generic Medicine Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Generic Medicine Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Generic Medicine Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Generic Medicine Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Generic Medicine Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Generic Medicine Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Generic Medicine Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Generic Medicine Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Generic Medicine Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Generic Medicine Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Generic Medicine Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Generic Medicine Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Generic Medicine Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Generic Medicine Picture

Figure 2. Global Generic Medicine Revenue Market Share by Type in 2020

Figure 3. Simple Generic Drugs

Figure 4. Super Generic Drugs

Figure 5. Biosimilars

Figure 6. By Application:

Figure 7. CNS

Figure 8. Cardiovascular

Figure 9. Respiratory

Figure 10. Rheumatology

Figure 11. Diabetes

Figure 12. Oncology

Figure 13. Generic Medicine Revenue Market Share by Application in 2020

Figure 14. CNS Picture

Figure 15. Cardiovascular Picture

Figure 16. Respiratory Picture

Figure 17. Rheumatology Picture

Figure 18. Diabetes Picture

Figure 19. Oncology Picture

Figure 20. Others Picture

Figure 21. Global Generic Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 22. Global Generic Medicine Revenue and Forecast (2016-2026) & (USD Million)

Figure 23. Global Generic Medicine Revenue Market Share by Region (2016-2026)

Figure 24. Global Generic Medicine Revenue Market Share by Region in 2020

Figure 25. North America Generic Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 26. Europe Generic Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 27. Asia-Pacific Generic Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 28. South America Generic Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 29. Middle East and Africa Generic Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 30. Generic Medicine Market Drivers

Figure 31. Generic Medicine Market Restraints

Figure 32. Generic Medicine Market Trends

Figure 33. Teva Recent Developments and Future Plans

Figure 34. Novartis - Sandoz Recent Developments and Future Plans

Figure 35. Mylan Recent Developments and Future Plans

Figure 36. Sun Pharmaceutical Recent Developments and Future Plans

Figure 37. Aspen Recent Developments and Future Plans

Figure 38. Fresenius Kabi Recent Developments and Future Plans

Figure 39. Pfizer (Hospira) Recent Developments and Future Plans

Figure 40. Sanofi Recent Developments and Future Plans

Figure 41. Aurobindo Recent Developments and Future Plans

Figure 42. Lupin Recent Developments and Future Plans

Figure 43. Dr. Reddy's Recent Developments and Future Plans

Figure 44. Apotex Recent Developments and Future Plans

Figure 45. Cipla Recent Developments and Future Plans

Figure 46. ENDO (Par Pharmaceutical) Recent Developments and Future Plans

Figure 47. Stada Arzneimittel Recent Developments and Future Plans

Figure 48. Krka Group Recent Developments and Future Plans

Figure 49. Nichi-Iko Pharmaceutical Recent Developments and Future Plans

Figure 50. Valeant Recent Developments and Future Plans

Figure 51. Zydus Cadila Recent Developments and Future Plans

Figure 52. Hikma Recent Developments and Future Plans

Figure 53. Global Generic Medicine Revenue Share by Players in 2020

Figure 54. Generic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 55. Global Top 3 Players Generic Medicine Revenue Market Share in 2020

Figure 56. Global Top 10 Players Generic Medicine Revenue Market Share in 2020

Figure 57. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 58. Global Generic Medicine Revenue Share by Type in 2020

Figure 59. Global Generic Medicine Market Share Forecast by Type (2021-2026)

Figure 60. Global Generic Medicine Revenue Share by Application in 2020

Figure 61. Global Generic Medicine Market Share Forecast by Application (2021-2026)

Figure 62. North America Generic Medicine Sales Market Share by Type (2016-2026)

Figure 63. North America Generic Medicine Sales Market Share by Application (2016-2026)

Figure 64. North America Generic Medicine Revenue Market Share by Country (2016-2026)

Figure 65. United States Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Canada Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Mexico Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Europe Generic Medicine Sales Market Share by Type (2016-2026)

Figure 69. Europe Generic Medicine Sales Market Share by Application (2016-2026)

Figure 70. Europe Generic Medicine Revenue Market Share by Country (2016-2026)

Figure 71. Germany Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. France Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. United Kingdom Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Russia Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Italy Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Asia-Pacific Generic Medicine Sales Market Share by Type (2016-2026)

Figure 77. Asia-Pacific Generic Medicine Sales Market Share by Application (2016-2026)

Figure 78. Asia-Pacific Generic Medicine Revenue Market Share by Region (2016-2026)

Figure 79. China Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Japan Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. South Korea Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. India Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Southeast Asia Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Australia Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. South America Generic Medicine Sales Market Share by Type (2016-2026)

Figure 86. South America Generic Medicine Sales Market Share by Application (2016-2026)

Figure 87. South America Generic Medicine Revenue Market Share by Country (2016-2026)

Figure 88. Brazil Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Argentina Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 90. Middle East and Africa Generic Medicine Sales Market Share by Type (2016-2026)

Figure 91. Middle East and Africa Generic Medicine Sales Market Share by Application (2016-2026)

Figure 92. Middle East and Africa Generic Medicine Revenue Market Share by Country (2016-2026)

Figure 93. Turkey Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 94. Saudi Arabia Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 95. UAE Generic Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 96. Methodology

Figure 97. Research Process and Data Source